tTMB-P1(5.37) Reference Standard
CBP80001-1
询 价
索取COA
产品描述
产品数据库
| I. Background | |||||||||||||||||||||||||||||||||||
|
Tumor mutational burden (TMB) shows great promise as a biomarker for immuno-oncology (I-O) therapy response, but progress is hindered by the lack of a standardized TMB measurement by targeted NGS panels, and an absence of TMB reference materials.
|
|||||||||||||||||||||||||||||||||||
